Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Accumulating evidence suggests that mesenchymal stem cells (MSCs) are recruited to the tumor microenvironment; however, controversy exists regarding their role in solid tumors. In this study, we identified and confirmed the presence of carcinoma-associated MSCs (CA-MSCs) in the majority of human ovarian tumor samples that we analyzed. These CA-MSCs had a normal morphologic appearance, a normal karyotype, and were nontumorigenic. CA-MSCs were multipotent with capacity for differentiating into adipose, cartilage, and bone. When combined with tumor cells in vivo, CA-MSCs promoted tumor growth more effectively than did control MSCs. In vitro and in vivo studies suggested that CA-MSCs promoted tumor growth by increasing the number of cancer stem cells. Although CA-MSCs expressed traditional MSCs markers, they had an expression profile distinct from that of MSCs from healthy individuals, including increased expression of BMP2, BMP4, and BMP6. Importantly, BMP2 treatment in vitro mimicked the effects of CA-MSCs on cancer stem cells, while inhibiting BMP signaling in vitro and in vivo partly abrogated MSC-promoted tumor growth. Taken together, our data suggest that MSCs in the ovarian tumor microenvironment have an expression profile that promotes tumorigenesis and that BMP inhibition may be an effective therapeutic approach for ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The tumor-supporting properties of MSC (immunomodulation, angiogenesis, cell survival or migration) often seem to be enhanced in tumor-derived MSC populations [45, 74, 75].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [45]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Chamberlain, G., Fox, J., Ashton, B., & Middleton, J. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0197 · Cited by 2,381
Genes Expressed in Human Tumor Endothelium
Croix, B. S., Rago, C., Velculescu, V., Traverso, G., Romans, K. E., Montgomery, E., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B., et al. (2000) · Science · doi:10.1126/science.289.5482.1197 · Cited by 1,845
Efficient tumour formation by single human melanoma cells
Quintana, E., Shackleton, M., Sabel, M. S., Fullen, D. R., Johnson, T. M., & Morrison, S. J. (2008) · Nature · doi:10.1038/nature07567 · Cited by 1,796
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals
Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noël, D., & Jorgensen, C. (2003) · Blood · doi:10.1182/blood-2003-04-1193 · Cited by 1,166
Role of tumor-associated macrophages in tumor progression and invasion
Mantovani, A., Schioppa, T., Porta, C., Allavena, P., & Sica, A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9001-7 · Cited by 888
Spaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K., Klopp, A., Hall, B., Andreeff, M., & Marini, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004992 · Cited by 807
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks
Liu, S., Ginestier, C., Ou, S. J., Clouthier, S. G., Patel, S. H., Monville, F., Korkaya, H., Heath, A., Dutcher, J., Kleer, C. G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0538 · Cited by 611
Research works printed but not linked: 2
- 10.1634/stemcells.2008-0037 · DOI
- Ye, 2007, Histol Histopathol., 22, 1129
Cited by
Items 101–200 of 410
Cancer stem cells: the ‘heartbeat’ of gastric cancer
Xu, G., Shen, J., Yang, X., Sasahara, M., & Su, X. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0712-y · Cited by 79
“Despite the well-established links between BMP signaling and CSC functions in prostate cancer [132], breast cancer [133], ovarian cancer [134], and glioblastoma [135], to date there has been no direct evidence for a role of BMP signaling in GCSC biology, which requires further efforts to clarify the underlying relatio…”
BackgroundThe versatile role of exosomes in cancer progression: diagnostic and therapeutic implications
Sundararajan, V., Sarkar, F. H., & Ramasamy, T. S. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0378-4 · Cited by 67
Pal, A., Huang, W., Li, X., Toy, K. A., Nikolovska‐Coleska, Z., & Kleer, C. G. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0154 · Cited by 78
“In addition, BMP4 upregulation is a common event in the pathogenesis of human carcinomas, including breast cancer (39-41).”
Regulation of Ovarian Cancer Stem Cells or Tumor-Initiating Cells
Kwon, M. J., & Shin, Y. K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14046624 · Cited by 78
“reported that ovarian carcinoma associated-mesenchymal stem cells (CA-MSCs) within the ovarian tumor microenvironment promote tumor growth by increasing the number of CSC/TICs [86].”
BackgroundReciprocal modulation of mesenchymal stem cells and tumor cells promotes lung cancer metastasis
Fregni, G., Quinodoz, M., Möller, E., Vuille, J., Galland, S., Fusco, C., Martin, P., Letovanec, I., Provero, P., Rivolta, C., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.02.017 · Cited by 74
“Despite sharing the same cell surface markers and similar plasticity, BM- and T-MSCs display different features (McLean et al., 2011).”
Yin, Z., Jiang, K., Li, R., Dong, C., & Wang, L. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0926-6 · Cited by 73
“The existence of MSCs in other human epithelial tumors was subsequently reported, including in breast [75], ovarian [76], prostate [77], hepatocellular [78, 160, 161], colon [79], glioma [80], and pancreatic cancers [81].”
BackgroundTouboul, C., Lis, R., Al Farsi, H., Raynaud, C. M., Warfa, M., Althawadi, H., Mery, E., Mirshahi, M., & Rafii, A. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-28 · Cited by 75
Mesenchymal stromal cells as cancer promoters
Antoon, R., Overdevest, N., Saleh, A. H., & Keating, A. (2024) · Oncogene · doi:10.1038/s41388-024-03183-1 · Cited by 75
Ghosh, D., Peña, C. M., Quach, N. D., Xuan, B., Lee, A. H., & Dawson, M. (2020) · Journal of Cell Science · doi:10.1242/jcs.232470 · Cited by 76
“, 2016) and ovarian carcinomas (McLean et al., 2011), and gliomas (Ho et al.”
BackgroundEGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH+ Ovarian Cancer Cells
Bai, S., Ingram, P., Chen, Y., Deng, N., Pearson, A. T., Niknafs, Y. S., O’Hayer, P., Wang, Y., Zhang, Z., Boscolo, E., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0225 · Cited by 75
“Cancer Res; 76(21) November 1, 2016 Cancer Research 6404”
BackgroundMethodInfluentialSelf-citationCancer stem cells: Recent insights and therapies
Zhou, H., Tan, L., Liu, B., & Guan, X. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115441 · Cited by 73
Zhu, M., Wang, M., Yang, F., Tian, Y., Cai, J., Yang, H., Fu, H., Mao, F., Zhu, W., Qian, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7767 · Cited by 73
“Recently, tumor associated MSC were sequentially reported to be isolated from many kinds of solid tumors [21, 22, 23].”
The Role of MSCs in the Tumor Microenvironment and Tumor Progression
Ahn, S. Y. (2020) · Anticancer Research · doi:10.21873/anticanres.14284 · Cited by 73
Shen, Y., Xue, C., Li, X., Ba, L., Gu, J., Sun, Z., Han, Q., & Zhao, R. C. (2019) · Stem Cells and Development · doi:10.1089/scd.2018.0125 · Cited by 72
“Compared with normal MSCs, the proliferation, migration, and tumor support functions of MSCs were significantly enhanced [31–34].”
The Role of Cancer Stem Cells and Mechanical Forces in Ovarian Cancer Metastasis
Bregenzer, M. E., Horst, E. N., Mehta, P., Novak, C. M., Repetto, T., & Mehta, G. (2019) · Cancers · doi:10.3390/cancers11071008 · Cited by 64
“CA-MSCs also increase the population of ovarian CSCs through upregulation of TGF-β/BMP family members [63].”
BackgroundRitter, A., Kreis, N., Hoock, S. C., Solbach, C., Louwen, F., & Yuan, J. (2022) · Cancers · doi:10.3390/cancers14163908 · Cited by 72
Javan, M. R., Khosrojerdi, A., & Moazzeni, S. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00840 · Cited by 67
“As well, T-MSCs obtained from ovarian cancer increased the proliferation of tumor cells (86).”
BackgroundMechanisms and clinical implications of tumor heterogeneity and convergence on recurrent phenotypes
McQuerry, J. A., Chang, J. T., Bowtell, D. D. L., Cohen, A. L., & Bild, A. H. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1587-4 · Cited by 71
“normal genome, promote tumor growth and stemness phenotype, and have high BMP2 and BMP4 expression [83].”
BackgroundMelzer, C., von der Ohe, J., & Hass, R. (2018) · Stem Cells · doi:10.1002/stem.2829 · Cited by 70
Targeting the tumour microenvironment in platinum-resistant ovarian cancer
Cummings, M., Freer, C., & Orsi, N. M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.02.007 · Cited by 69
To grab the stroma by the horns: From biology to cancer therapy with mesenchymal stem cells
Droujinine, I. A., Eckert, M. A., & Zhao, W. (2013) · Oncotarget · doi:10.18632/oncotarget.1040 · Cited by 69
“Similar results were obtained by McLean et al, who demonstrated that MSC-like cells isolated from human tumors induce the growth of tumors and the self-renewal of putative CSCs at least in part via BMP secretion (which has been previously shown to be involved in tumor progression) (65).”
BackgroundResultSuh, D. H., Kim, H. S., Kim, B., & Song, Y. S. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.011 · Cited by 69
An evolving paradigm of cancer stem cell hierarchies: therapeutic implications
Cole, A. J., Fayomi, A. P., Anyaeche, V. I., Bai, S., & Buckanovich, R. J. (2020) · Theranostics · doi:10.7150/thno.41647 · Cited by 69
“In various cancer types, carcinoma associated MSCs (CA-MSCs) have been shown to promote tumor ‘stemness’, increasing tumor growth, chemotherapy resistance, and metastasis (83,84).”
BackgroundSelf-citationYang, X. F., Hou, J., Han, Z., Wang, Y., Hao, C., Wei, L., & Shi, Y. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-5 · Cited by 65
“MSCs can enhance CSCs proliferation by secreting cytokines, IL-6 and CXCL7, thereby facilitating the tumor growth [163-165].”
BackgroundWilczyński, J. R., Wilczyński, M., & Paradowska, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052496 · Cited by 65
Dynamic Interactions Between Cancer Stem Cells and Their Stromal Partners
Park, T. S., Donnenberg, V. S., Donnenberg, A. D., Zambidis, E. T., & Zimmerlin, L. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-013-0036-5 · Cited by 55
“Cancer-associated MSCs were shown to rely on altered BMP production to regulate ovarian CSCs and their tumorigenesis [54].”
BackgroundKlymenko, Y., & Nephew, K. P. (2018) · Cancers · doi:10.3390/cancers10090295 · Cited by 65
Frisbie, L. G., Pressimone, C. A., Dyer, E., Baruwal, R., Garcia, G. L., Croix, C. M. S., Watkins, S. C., Calderone, M., Gorecki, G., Javed, Z., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114551 · Cited by 63
Montesinos, J. J., Mora-García, M. D. L., Mayani, H., Flores-Figueroa, E., García-Rocha, R., Fajardo-Orduña, G. R., Castro-Manrreza, M. E., Weiss-Steider, B., & Monroy-García, A. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0084 · Cited by 58
“The data are representative of three independent experiments. the isolation of MSCs from several tumors [8–13]; however, the presence of MSCs has not been demonstrated in NCx or in CeCa tissue.”
Virant‐Klun, I., Šuster, N. K., & Smrkolj, Š. (2016) · Journal of Ovarian Research · doi:10.1186/s13048-016-0221-3 · Cited by 62
“tumors, and support cancer stem cells [38–49].”
Ho, C.-M., Chang, S.-F., Hsiao, C.-C., Chien, T.-Y., & Shih, D. T.-B. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-23 · Cited by 58
“[37], suggesting that Figure 6 Expression of surface markers on cells deriving from ascites and OSA tissues of patients, and ascites of endometriosis”
BackgroundMelzer, C., von der Ohe, J., & Hass, R. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0279-1 · Cited by 62
Okazaki, I., Noro, T., Tsutsui, N., Yamanouchi, E., Kuroda, H., Nakano, M., Yokomori, H., & Inagaki, Y. (2014) · Cancers · doi:10.3390/cancers6031220 · Cited by 61
“Cancer-associated mesenchymal stem cells (MSC) could cross-talk with tumor cells and secreted many growth factors and chemokines, which play crucial roles in tumor progression [158,159].”
BackgroundMechanisms of Ovarian Cancer Metastasis: Biochemical Pathways
Nakayama, K., Nakayama, N., Katagiri, H., & Miyazaki, K. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130911705 · Cited by 61
“In vitro and in vivo studies suggest that CA-MSCs promote tumor growth by increasing the number of cancer stem cells [41].”
BackgroundImmunological configuration of ovarian carcinoma: features and impact on disease outcome
Fucikova, J. P., Coosemans, A., Oršulić, S., Cibula, D., Vergote, I. B., Galluzzi, L., & Špíšek, R. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002873 · Cited by 62
Motohara, T., Yoshida, G. J., & Katabuchi, H. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.038 · Cited by 60
Stem cell therapy: a look at current research, regulations, and remaining hurdles.
Reisman, M., & Adams, K. T. (2014) · PubMed Central · Cited by 60
Papait, A., Stefani, F. R., Cargnoni, A., Magatti, M., Parolini, O., & Silini, A. R. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00447 · Cited by 50
Targeting ovarian cancer stem cells: a new way out
Ma, H., Tian, T., & Cui, Z. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03244-4 · Cited by 58
“It has been proven to be a useful marker for CSCs and is widely used to isolate CSCs in various malignancies, including OC [86, 87].”
BackgroundSlama, Y., Ah-Pine, F., Khettab, M., Arcambal, A., Begue, M., Dutheil, F., & Gasque, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713511 · Cited by 57
“Then, MSCs are regulated by the pro-inflammatory environment of the TME, by mediators secreted by tumor cells, and may adopt a protumorigenic phenotype [91,96].”
BackgroundFibroblasts as Turned Agents in Cancer Progression
Wieder, R. (2023) · Cancers · doi:10.3390/cancers15072014 · Cited by 57
López, Á. V., García, M. N. V., Melen, G. J., Martínez, A. E., Cubillo, I., García-Castro, J., Ramírez, M. R., & Zapata, A. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084496 · Cited by 57
“Furthermore, BMP4 produced by tumor microenvironment seems to be important for the biology of numerous hematological [12,19], and non-hematological tumors [20,21,22] although few studies have analyzed the cellular component responsible for such production, the autocrine effects or the stimulus responsible for this pro…”
BackgroundIn Vivo Cell Fusion between Mesenchymal Stroma/Stem-Like Cells and Breast Cancer Cells
Melzer, C., von der Ohe, J., & Hass, R. (2019) · Cancers · doi:10.3390/cancers11020185 · Cited by 57
“Furthermore, during indirect interaction with ovarian cancer cells, human MSC were suggested to promote tumor growth and support proliferation and survival [28].”
BackgroundHarnessing mesenchymal stem cell homing as an anticancer therapy
Hagenhoff, A., Bruns, C. J., Zhao, Y., von Lüttichau, I., Niess, H., Spitzweg, C., & Nelson, P. J. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1196179 · Cited by 47
Regulatory Role of Quiescence in the Biological Function of Cancer Stem Cells
Lee, S. H., Reed-Newman, T. C., Anant, S., & Ramasamy, T. S. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10031-8 · Cited by 56
Gastric cancer-derived MSC-secreted PDGF-DD promotes gastric cancer progression
Huang, F., Wang, M., Yang, T., Cai, J., Zhang, Q., Sun, Z., Wu, X., Zhang, X., Zhu, W., Qian, H., et al. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1723-2 · Cited by 56
“To date, few studies have revealed the mechanism of human solid tumor-associated MSCs on cancer cells (Chiba et al. 2008; McLean et al. 2011).”
BackgroundRole of tumor microenvironment in ovarian cancer metastasis and clinical advancements
Wang, Y., Zhu, N., Liu, J., Chen, F., Song, Y., Ma, Y., Yang, Z., & Wang, D. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06508-0 · Cited by 56
Mesenchymal Cell Interaction with Ovarian Cancer Cells Triggers Pro-Metastatic Properties
Lis, R., Touboul, C., Raynaud, C. M., Malek, J. A., Suhre, K., Mirshahi, M., & Rafii, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038340 · Cited by 47
“This is consistent with reports of MCs modifying ovarian cancer cells behavior [7,8,11,12,17].”
BackgroundResultInfluentialJiramongkolchai, P., Owens, P., & Hong, C. C. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160069 · Cited by 55
“In addition, although BMP7 expression was low to absent from primary tumours, BMP7 expression was increased in bone metastatic prostate cancer and overexpression of Noggin inhibited growth of BMP7 positive osteolytic cancer lesions [101].”
BackgroundInfluentialWang, M., Chen, B., Sun, X., Zhao, X., Zhao, Y., Sun, L., Xu, C., Shen, B., Su, Z., Xu, W., et al. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.09.036 · Cited by 55
Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma
Bonneau, C., Rouzier, R., Geyl, C., Cortez, A., Castela, M., Lis, R., Daraï, É., & Touboul, C. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.10.024 · Cited by 54
Guo, X., Xiong, L., Zou, L., & Zhao, J. (2012) · Pathology & Oncology Research · doi:10.1007/s12253-011-9488-2 · Cited by 53
“example, BMP4 induced migration and invasion of colon, ovarian, and pancreatic cancer cells [10–12].”
BackgroundIFN-γ-Secreting-Mesenchymal Stem Cells Exert an Antitumor Effect In Vivo via the TRAIL Pathway
Yang, X., Du, J., Xu, X., Xu, C., & Song, W. (2014) · Journal of Immunology Research · doi:10.1155/2014/318098 · Cited by 52
Pagnotti, G. M., Adler, B. J., Green, D. E., Chan, M. E., Frechette, D. M., Shroyer, K. R., Beamer, W. G., Rubin, J. E., & Rubin, C. T. (2012) · Bone · doi:10.1016/j.bone.2012.05.004 · Cited by 52
“In the case of epithelial ovarian carcinoma, not only are MSC “universally present” in human ovarian cancer, but these cancer associated MSCs promoted the growth and abnormal characteristics of cocultured ovarian cell lines in vitro [26].”
BackgroundTao, Y., Li, H., Huang, R., Mo, D., Zeng, T., Fang, M., & Li, M. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000489586 · Cited by 52
Parascandolo, A., Rappa, F., Cappello, F., Kim, J., Cantu, D. A., Chen, H., Mazzoccoli, G., Hematti, P., Castellone, M. D., Salvatore, M., et al. (2017) · Scientific Reports · doi:10.1038/srep41416 · Cited by 51
“Indeed, tumor-associated MSCs recently characterized in ovarian carcinoma and prostate cancer have similar phenotype and functionality as BM MSC but altered growth factor expression profile 55,56 .”
Revisiting ovarian cancer microenvironment: a friend or a foe?
Zhang, B., Chen, F., Xu, Q., Han, L., Xu, J., Gao, L., Sun, X., Li, Y., Li, Y., Qian, M., et al. (2017) · Protein & Cell · doi:10.1007/s13238-017-0466-7 · Cited by 51
“This article is an open access publication P ro te in & C e ll morphogenetic protein (BMP) signaling network, which plays important roles in cancer progression (McLean et al., 2011).”
BackgroundThe Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor Microenvironment
Varas‐Godoy, M., Rice, G. E., & Illanes, S. E. (2017) · Stem Cells International · doi:10.1155/2017/5263974 · Cited by 52
“One of the characteristic of the CA-MSCs is the upregulation of the TGF-β superfamily/BMP family members in comparison with control MSCs, and this activation in the BMP signaling pathways increases the population of ovarian CSCs promoting the CSC proliferation [75].”
BackgroundLin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment
Ma, W., Ma, J., Xu, J., Qiao, C., Branscum, A. J., Cárdenas, A., Baron, A. T., Schwartz, P. E., Maihle, N. J., & Huang, Y. (2012) · Cell Cycle · doi:10.4161/cc.23028 · Cited by 50
“Further, inhibition of BMP2/4 by Noggin, an extracellular BMP inhibitor, results in partial abrogation of CA-MSC-promoted tumor growth in mice.(7) In addition to BMPs, specific stem cell factors such as Lin28 and Oct4 may contribute to regulating ovarian CSCs and tumor progression.”
BackgroundResultInfluentialMusrap, N., & Diamandis, E. P. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0353 · Cited by 49
“Combining cancer-associatedMSCs with tumor cells in vivo and in vitro has been shown to result in increased expression of the bone morphogenetic protein (BMP) signaling network, which has several pathologic roles in cancer progression (55).”
BackgroundGu, Z.-W., He, Y., Wang, W., Tian, Q., & Di, W. J. (2019) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1800190 · Cited by 49
Tumor resident mesenchymal stromal cells endow naïve stromal cells with tumor-promoting properties
Ren, G., Liu, Y. F., Zhao, X., Zhang, J. J., Zheng, B., Yuan, Z.-R., Zhang, L., Qu, X., Tischfield, J. A., Shao, C., et al. (2013) · Oncogene · doi:10.1038/onc.2013.387 · Cited by 49
Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages
Castells, M., Thibault, B., Mery-Lamarche, E., Golzio, M., Pasquet, M., Hennebelle, I., Bourin, P., Mirshahi, M., Delord, J. P., Querleu, D., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.07.020 · Cited by 49
“When BM-MSCs are recruited to tumor stroma, they can differentiate into myofibroblast-like tumor-associated Fibroblasts (TAFs) or CA-MSCs and become part of the tumor microenvironment that supports tumor growth [21–23].”
BackgroundGarcía‐Rocha, R., Moreno-Lafont, M. C., Mora‐García, M. D. L., Weiss‐Steider, B., Montesinos, J. J., Piña‐Sánchez, P., & Monroy, A. (2015) · Cytokine · doi:10.1016/j.cyto.2015.09.001 · Cited by 48
Kim, T. H., Suh, D. H., Kim, M., & Song, Y. S. (2014) · BioMed Research International · doi:10.1155/2014/132702 · Cited by 47
Khammanivong, A., Gopalakrishnan, R., & Dickerson, E. B. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-260 · Cited by 47
“While these studies confirm that the inhibition of BMP signaling plays a role in maintaining progenitor cells in a CSC-like state, contradictory reports show that activation by BMP2 enhances CSC-like populations in ovarian carcinoma [57], and BMP4 stimulates an epithelial-to-mesenchymal and a CSC-like phenotype in a s…”
BackgroundMesenchymal Stem Cells for Mitigating Radiotherapy Side Effects
Wang, K., Cui, W.-W., Xu, Y., Tao, A., Lan, T., Li, T., & Luo, L. (2021) · Cells · doi:10.3390/cells10020294 · Cited by 46
Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies
Mancini, S. J. C., Balabanian, K., Corre, I., Gavard, J., Lazennec, G., Bousse‐Kerdilès, M. L., Louache, F., Maguer‐Satta, V., Mazure, N. M., Mechta‐Grigoriou, F., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.766275 · Cited by 46
Functions of the CXC ligand family in the pancreatic tumor microenvironment
Lee, N., Nikfarjam, M., & He, H. Z. (2018) · Pancreatology · doi:10.1016/j.pan.2018.07.011 · Cited by 44
Mesenchymal/stromal stem cells: necessary factors in tumour progression
Li, X., Fan, Q., Peng, X., Yang, S., Wei, S., Liu, J., Yang, L., & Li, H. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01107-0 · Cited by 43
“The level of BMP is positively correlated with tumour growth in multiple tumours (such as melanoma and ovarian cancer), and tumour growth can be reversed by BMP antagonists [47, 79, 80].”
BackgroundInfluentialDing, D., Liu, H.-W., & Chu, T. (2016) · Journal of Cancer · doi:10.7150/jca.16116 · Cited by 43
“demonstrated that MSCs derived from ovarian cancer tissue could promote tumor growth via altered BMP production [16].”
BackgroundKe, C.-C., Liu, R.-S., Suetsugu, A., Kimura, H., Ho, J. H., Lee, O. K., & Hoffman, R. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069658 · Cited by 39
“Other studies have shown that MSCs enhance the cancer stem cell population in vitro [25,26].”
ResultJung, P. Y., Ryu, H., Rhee, K., Hwang, S., Lee, C.-G., Gwon, S.-Y., Kim, J., Kim, J., Yoo, B., Baik, S. K., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.017 · Cited by 42
Paracrine Signals From Liver Sinusoidal Endothelium Regulate Hepatitis C Virus Replication
Rowe, I. A. C., Galsinh, S. K., Wilson, G. K., Parker, R., Durant, S., Lazar, C., Branza‐Nichita, N., Bicknell, R., Adams, D., Balfe, P., et al. (2013) · Hepatology · doi:10.1002/hep.26571 · Cited by 42
Atiya, H. I., Frisbie, L. G., Goldfeld, E., Orellana, T. J., Donnellan, N. M., Modugno, F., Calderon, M. J., Watkins, S. C., Zhang, R., Elishaev, E., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1294 · Cited by 41
“MSCs were isolated following previously described protocols (9,12).”
BackgroundMethodVera, N., Acuña‐Gallardo, S., Grünenwald, F., Cáceres‐Verschae, A., Realini, O., Acuña, R. A., Lladser, Á., Illanes, S. E., & Varas‐Godoy, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20204972 · Cited by 40
Peng, J., Yoshioka, Y., Mandai, M., Matsumura, N., Baba, T., Yamaguchi, K. D., Hamanishi, J., Kharma, B., Murakami, R., Abiko, K., et al. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22283 · Cited by 40
Lis, R., Touboul, C., Halabi, N. M., Madduri, A. S., Querleu, D., Mezey, J. G., Malek, J. A., Suhre, K., & Rafii, A. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-59 · Cited by 39
Wang, M., Yang, F., Qiu, R., Zhu, M., Zhang, H., Xu, W., Shen, B., & Zhu, W. (2018) · Cancer Medicine · doi:10.1002/cam4.1355 · Cited by 39
“Recently, cancer tissue- derived MSCs have been successively isolated and characterized in many solid tumors, including gastric cancer [16], ovarian carcinoma [17], hepatocellular carcinoma [18], and pancreatic cancer [19].”
BackgroundWang, W., Wang, Q., Huang, D., Sun, Q.-K., Wu, S., Zhao, Y., Jia, W., Hu, D., & He, Y. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.01.011 · Cited by 39
Hover, L. D., Young, C. D., Bhola, N. E., Wilson, A. J., Khabele, D., Hong, C. C., Moses, H. L., & Owens, P. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.032 · Cited by 37
Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Epithelial–Mesenchymal Transition
Kletukhina, S. K., Neustroeva, O., James, V. H., Rizvanov, A. A., & Gomzikova, M. O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194813 · Cited by 37
“TA-MSCs show a stronger tumor-promoting capacity through microenvironment modulation [86].”
BackgroundThe Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
Wang, Y., Huang, Z., Li, B., Liu, L., & Huang, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.863541 · Cited by 37
BMP signaling is a therapeutic target in ovarian cancer
Fukuda, T., Fukuda, R., Tanabe, R., Koinuma, D., Koyama, H., Hashizume, Y., Moustakas, A., Miyazono, K., & Heldin, C. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00377-w · Cited by 35
Mesothelial Cells Facilitate Cancer Stem like properties in spheroids of ovarian cancer cells
Shishido, A., Mori, S., Yokoyama, Y., Hamada, Y., Minami, K., Qian, Y., Wang, J., Hirose, H., Wu, X., Kawaguchi, N., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6605 · Cited by 34
“Spheroid or sphere formation is one of the hallmarks of CSCs. Bone morphogenetic protein (BMP) 2 promoted the phosphorylation of SMAD5 and induced epithelial-mesenchymal transition (EMT) (26).”
BackgroundIn vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
House, C. D., Hernandez, L. F., & Annunziata, C. M. (2015) · Journal of Visualized Experiments · doi:10.3791/52446 · Cited by 34
Gao, T., Yu, Y., Cong, Q., Wang, Y., Sun, M., Yao, L., Xu, C., & Jiang, W. (2018) · BMC Cancer · doi:10.1186/s12885-018-4918-0 · Cited by 34
Baba, K., Yamazaki, Y., Sone, Y., Sugimoto, Y., Moriyama, K., Sugimoto, T., Kumazawa, K., Shimakura, Y., & Takeda, A. (2019) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2019.01.020 · Cited by 34
Hu, J., Zhao, W., Huang, Y., Wang, Z., Jiang, T., & Wang, L. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0751-z · Cited by 34
Mesenchymal Stem/Stromal Cells Derived from Cervical Cancer Promote M2 Macrophage Polarization
Cortés-Morales, V. A., Chávez-Sanchéz, L., Rocha‐Zavaleta, L., Espíndola-Garibay, S., Monroy-García, A., Castro-Manrreza, M. E., Fajardo-Orduña, G. R., Apresa-García, T., de la Barrera, M. G., Mayani, H., et al. (2023) · Cells · doi:10.3390/cells12071047 · Cited by 34
“migrate to sites of inflammation and have been isolated from different types of cancer, such as osteosarcoma [2], gastric cancer [3], neuroblastoma [4] and ovarian cancer [5].”
BackgroundLawrenson, K., Grün, B., Lee, N., Mhawech-Fauceglia, P. Y., Kan, J., Swenson, S. D., Lin, Y. G., Pejovic, T. B., Millstein, J., & Gayther, S. A. (2014) · International Journal of Cancer · doi:10.1002/ijc.29092 · Cited by 34
“Several reports have shown that MSCs can be tumor promoting in many solid tumors including breast, prostate and ovarian carcinoma.(11,17) In our study, we established heterotypic models of EOC, both in vitro and heterotypic in vivo, to directly compare NOFs and MSCs as potential sources of CAFs in EOCs.”
BackgroundRole of mesenchymal cells in the natural history of ovarian cancer: a review
Touboul, C., Vidal, F., Pasquier, J., Lis, R., & Rafii, A. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0271-5 · Cited by 33
Deepening a Simple Question: Can MSCs Be Used to Treat Cancer?
Gomes, J., Assoni, A. F., Pelatti, M., Coatti, G. C., Okamoto, O. K., & Zatz, M. (2017) · Anticancer Research · doi:10.21873/anticanres.11881 · Cited by 32
Tumor-associated mesenchymal stem/stromal cells in tumor microenvironment and carcinogenesis
Sun, L., Cao, X., Zhou, B., Mei, J., Zhao, X., Li, Y., Yao, Y., & Wang, M. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00688-7 · Cited by 33
“Research shows that TA-MSCs Two others naïve MSC types, namely Adipose tissue-derived MSCs (AD-MSCs) and local tissue MSCs, are frequently used as controls to investigate TA-MSCs, particularly in studies investigating ovarian tumors and breast cancer [55, 60, 61, 103].”
InfluentialCheng, J., Duan, L.-X., Yu, Y., Wang, P., Feng, J.-L., Feng, G. Z., & Liu, Y. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00599-0 · Cited by 31
“For example, MSCs in ovarian cancer increased the proportion of CSCs by secreting BMP2 [32].”
BackgroundZhang, X., Li, N., Zhu, Y., & Wen, W. (2022) · Cancer Medicine · doi:10.1002/cam4.4521 · Cited by 31
Ramuta, T. Ž., & Kreft, M. E. (2022) · Cancers · doi:10.3390/cancers14153761 · Cited by 31
The Role of Mesenchymal Stem Cells in Modulating the Breast Cancer Microenvironment
Zhang, L. (2023) · Cell Transplantation · doi:10.1177/09636897231220073 · Cited by 31
“For example, in human ovarian cancer, tumor-associated MSCs (T-MSCs) were discovered to produce more bone morphogenetic proteins (BMPs) compared with normal MSCs (N-MSCs) derived from AT and BM, including BMP2, BMP4, and BMP6 69 .”
BackgroundRole of the Microenvironment in Ovarian Cancer Stem Cell Maintenance
Pasquier, J., & Rafii, A. (2012) · BioMed Research International · doi:10.1155/2013/630782 · Cited by 31
Rohrich, R. J., & Wan, D. (2019) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000005207 · Cited by 30
Metadata
- Authors
- McLean, K., Gong, Y., Choi, Y., Deng, N., Yang, K., Bai, S., Cabrera, L., Keller, E., McCauley, L., Cho, K. R., & Buckanovich, R. J.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Buckanovich, Ronald J.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-08-01
- Volume
- 121
- Issue
- 8
- Pages
- 3206-3219
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3148732
- OpenAlex
- W1970698543
- Cited by
- 380
- References
- 57
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 20 · 2023: 44 · 2022: 29 · 2021: 34 · 2020: 19 · 2019: 25 · 2018: 28 · 2017: 23 · 2016: 30 · 2015: 22 · 2014: 28 · 2013: 28 · 2012: 26
- FWCI
- 13.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Damon Runyon Cancer Research Foundation
- University of Michigan (48109)
- College of Pharmacy, University of Michigan
- U.S. Public Health Service (P01 093900)
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- ovarian carcinoma, mesenchymal stem cells, cancer stem cells, tumor microenvironment, BMP signaling, BMP-2, BMP4, BMP6, carcinogenesis, stem cell recruitment, multipotency
- MeSH terms
- Cell Differentiation, Cell Separation, Female, Humans, Models, Biological, Ovarian Neoplasms, Phenotype, Neoplastic Stem Cells, Signal Transduction, Gene Expression Regulation, Neoplastic, Bone Morphogenetic Proteins, Gene Expression Profiling, Cell Line, Tumor, Tumor Microenvironment, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.